期刊文献+

坦索罗辛治疗输尿管单枚小结石的作用观察 被引量:2

暂未订购
导出
摘要 目的评价选择性α1-肾上腺素受体阻滞剂(坦索罗辛)在治疗输尿管单枚小结石中的临床效果。结果对选取的126例单侧输尿管结石的患者随机分为两个组进行药物治疗,两组间年龄、性别、结石大小统计学差异不显著。A组(n=63)服用坦索罗辛(0.2mg/qn),B组(n=63)服用排石颗粒(5g,3/d),共服药2周,通过询问症状和检查B超,了解疼痛缓解时间和程度,排石率,排石时间,并观察不良反应。结果 A组排石率为85.7%(54/63),B组排石率为50.8%(32/63),两组间差异有统计学意义(P<0.01)。A组平均排石天数为(4.6±2.7)d,B组患者为(7.6±2.5)d,两组间差异显著(P<0.01)。结论坦索罗辛可明显提高结石排出率,减少排石时间,缓解绞痛症状并减少手术疗法的干预率。选择性α1-肾上腺素受体阻滞剂(坦索罗辛)可有效地用于输尿管结石的治疗。
出处 《中国现代药物应用》 2010年第20期135-136,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献9

  • 1PORPIGLIAF,DESTEFANISP,FIORIC,et al.Effectiveness of nifedipine and deflazacort in the management of distal ureter stones.U rology,2000,56 (4):579-583.
  • 2陈孝平.外科学[M].北京:人民卫生出版社,2004.452.
  • 3DELLABELLAM,MILANESEG,MUZZONIGROG.Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones.J U rol,2003,170 11:2202-2205.
  • 4KUPELIB,IRKILATAL,GUROCAKS,et al.Does tam sulosin enhance lower ureteral stone clearance with or without shock wave lithotrip sy.Adult U rol,2004,64 (10):1111 -1115.
  • 5SIGALAS,DELLABELLAM,MILANESEG,et al.Evidence for the presence of alpha1 adrenocep tor subtypes in the human ureter.Neurourol U rodyn,2005,24 (2):142-148.
  • 6YILMAZ E,BATISLAM E,BASAR M M,et al.The comparison and efficacy of 3 different alpha1 -adrenergic blockers for distal ureteral stones.J U rol,2005,173 (6):2010-2012.
  • 7Cervenakov I,Fillo J,Mardiak J et al.Speedy elimination of ureterolithiasis in lower part of ureters with alpha1 blocker tamsulosin.Int Urol Neprhol,2002,34:25.
  • 8Dellabella M,Milanese G,Muzzonigro G.Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones.J Urol,2003,170:2 202.
  • 9曹正国,诸禹平,苏红,吴斌,孙友文,董晓程.坦索洛辛在输尿管镜碎石术治疗输尿管下段结石中的作用[J].临床泌尿外科杂志,2008,23(6):450-452. 被引量:3

二级参考文献10

  • 1权伟合,吴振启,李虎宜,梁志恒,王凉梅.α_1受体阻滞剂辅助治疗提高ESWL后上尿路结石清除率[J].临床泌尿外科杂志,2007,22(3):210-212. 被引量:7
  • 2Bhagat S K, Chacko N K, Kekre N S, et al. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi[J]? J Urol, 2007, 177(6): 2185 -2188.
  • 3Ukhal M I, Malomuzh O I, Strashnyi V V, et al. The use of the alpha 1-adrenobloeker doxazosin in the pharmacotherapy of disorders of urine outflow of spastic ori gin[J]. Lik Sprava, 1998, 8: 118-121.
  • 4Sigala S, dellabella M, Milanese G, et al. Evidence for the presence of alphal adrenoceptor subtypes in the human ureter[J]. Neurourol Urodyn, 2005, 24(2) : 142-148.
  • 5Yilmaz E, Batislam E, Basar M M, et al. The comparison and efficacy of 3 different alphal-adrenergic blockers for distal ureteral stones[J].J Urol, 2005, 173(6): 2010-2012.
  • 6Resim S, Ekerbicer H C, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extraeorporeal shock wave lithotripsy [J]. Urology, 2005, 66(5): 945-948.
  • 7Hollingsworth J M,Rogers M A, Kaufman S R,et al. Medical therapy to facilitate urinary stone passage: a meta-analysis [J]. Lancet, 2006, 368 (9542): 1171 -1179.
  • 8Troxel S A, Jones A W, Magliola L, et al. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter[J]. J Endourol, 2006, 20(8): 565-568.
  • 9Gravas S, Tzortzis V, Karatzas A, et al. The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study[J]. Urol Res, 2007, 35(5):231-235.
  • 10Parsons J K, Hergan L A, Sakamoto K, et al. Efficacy of alpha-blockers for the treatment of ureteral stones [J]. J Urol, 2007, 177(3): 983-987.

共引文献12

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部